We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Eagle Materials
EXP
$6.57B
| $16.8M | 0.01% |
156,638
+32,074
| +26% | +$3.84M |
|
|
RVNC
1127
DELISTED
Revance Therapeutics, Inc.
RVNC
| $16.7M | 0.01% |
619,164
+260,044
| +72% | +$5.28M |
|
1128
Ormat Technologies
ORA
$6.65B
| $16.7M | 0.01% |
193,825
+6,689
| +4% | +$595K |
|
|
PACW
1129
DELISTED
PacWest Bancorp
PACW
| $16.7M | 0.01% |
738,118
-208,664
| -22% | -$5.61M |
|
1130
Lear
LEA
$8.18B
| $16.7M | 0.01% |
139,241
+4,983
| +4% | +$689K |
|
1131
The Ensign Group
ENSG
$10.7B
| $16.7M | 0.01% |
209,511
-14,467
| -6% | -$1.2M |
|
1132
Iovance Biotherapeutics
IOVA
$2.87B
| $16.7M | 0.01% |
1,738,385
-60,164
| -3% | -$694K |
|
1133
Corebridge Financial
CRBG
$15B
| $16.6M | 0.01% |
+842,857
| New | +$17.3M |
|
1134
Organon & Co
OGN
$3.57B
| $16.5M | 0.01% |
706,993
+16,077
| +2% | +$485K |
|
1135
Highwoods Properties
HIW
$3.47B
| $16.5M | 0.01% |
612,453
+249,896
| +69% | +$8.07M |
|
1136
Eagle Bancorp
EGBN
$845M
| $16.5M | 0.01% |
368,267
+131,408
| +55% | +$6.28M |
|
1137
United Bankshares
UBSI
$6.62B
| $16.5M | 0.01% |
461,184
-39,261
| -8% | -$1.46M |
|
1138
Element Solutions
ESI
$9.23B
| $16.5M | 0.01% |
1,012,834
+30,657
| +3% | +$572K |
|
|
SGMO
1139
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $16.4M | 0.01% |
3,355,829
+2,267,632
| +208% | +$11.6M |
|
|
LSXMK
1140
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $16.4M | 0.01% |
561,416
-50,448
| -8% | -$1.57M |
|
1141
First Bancorp
FBP
$4.38B
| $16.4M | 0.01% |
1,196,408
+11,360
| +1% | +$165K |
|
1142
ZTO Express
ZTO
$17.9B
| $16.3M | 0.01% |
678,351
-483,938
| -42% | -$12.6M |
|
1143
Sabra Healthcare REIT
SBRA
$5.37B
| $16.3M | 0.01% |
1,241,754
-50,426
| -4% | -$745K |
|
1144
CVR Energy
CVI
$3.13B
| $16.2M | 0.01% |
560,351
+55,890
| +11% | +$1.76M |
|
1145
iRhythm Holdings
IRTC
$4.2B
| $16.2M | 0.01% |
129,539
+5,949
| +5% | +$859K |
|
1146
Energy Recovery
ERII
$443M
| $16.2M | 0.01% |
743,683
-177,881
| -19% | -$4.01M |
|
1147
Phreesia
PHR
$773M
| $16.1M | 0.01% |
633,846
+116,504
| +23% | +$2.91M |
|
|
PINC
1148
DELISTED
Premier
PINC
| $16.1M | 0.01% |
475,740
+26,378
| +6% | +$962K |
|
1149
Houlihan Lokey
HLI
$9.02B
| $16.1M | 0.01% |
213,891
+3,222
| +2% | +$261K |
|
|
BCPC
1150
Balchem Corp
BCPC
$5.72B
| $16.1M | 0.01% |
132,535
+3,840
| +3% | +$500K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.